• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防慢性乙型肝炎病毒感染患者的肝细胞癌。

Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

机构信息

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.

出版信息

Oncology. 2011;81 Suppl 1:41-9. doi: 10.1159/000333258. Epub 2011 Dec 22.

DOI:10.1159/000333258
PMID:22212935
Abstract

Chronic hepatitis B (CHB) accounts for approximately 50% of the underlying etiologies for the development of hepatocellular carcinoma (HCC) worldwide. We reviewed the primary, secondary, and tertiary measures for the prevention of HCC in CHB patients. First, the most effective method is preventing the acquisition of CHB through global vaccination of infants. However, in patients already chronically infected, antiviral treatment using interferon or nucleoside analogs can prevent disease progression to cirrhosis or HCC. Studies have found viral replications indicated by a HBV DNA level to be a strong predictor for cirrhosis and HCC, irrespective of other viral and biochemical factors. Additionally, periodic surveillance using ultrasonography and serum α-fetoprotein every 3-6 months for earlier detection of HCC is also important so that curative treatments can be used. Once HCC occurs, hepatic resection is the mainstay of curative treatments. To prevent tumor recurrence after resection, adjuvant interferon treatments have been tried with promising results based on the assumption that they not only suppress viral activity but also have tumoricidal, antiangiogenetic, and antiproliferative effects. Using nucleoside analogs also has its rationale for preventing de novo tumor development in remnant liver, considering that viral replications are a strong risk factor for HCC. Optimal preventive plans should be further investigated in future studies.

摘要

慢性乙型肝炎(CHB)约占全球肝细胞癌(HCC)发展的 50%。我们回顾了 CHB 患者 HCC 的一级、二级和三级预防措施。首先,最有效的方法是通过婴儿全球疫苗接种预防 CHB 的发生。然而,对于已经慢性感染的患者,使用干扰素或核苷类似物的抗病毒治疗可以预防疾病进展为肝硬化或 HCC。研究发现,HBV DNA 水平所示的病毒复制是肝硬化和 HCC 的一个强有力的预测因素,而与其他病毒和生化因素无关。此外,通过每 3-6 个月进行超声和血清甲胎蛋白检测进行定期监测,以便更早地发现 HCC,这也很重要,这样就可以使用根治性治疗。一旦发生 HCC,肝切除术是根治性治疗的主要方法。为了防止切除后肿瘤复发,已尝试使用干扰素辅助治疗,根据假设,这些治疗不仅可以抑制病毒活性,还具有杀瘤、抗血管生成和抗增殖作用。使用核苷类似物也有其预防残留肝脏新发肿瘤的原理,因为病毒复制是 HCC 的一个强烈危险因素。在未来的研究中,应进一步探讨最佳的预防计划。

相似文献

1
Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.预防慢性乙型肝炎病毒感染患者的肝细胞癌。
Oncology. 2011;81 Suppl 1:41-9. doi: 10.1159/000333258. Epub 2011 Dec 22.
2
Prevention of hepatocellular carcinoma: beyond hepatitis B vaccination.肝细胞癌的预防:超越乙肝疫苗接种
Semin Oncol. 2015 Apr;42(2):316-28. doi: 10.1053/j.seminoncol.2014.12.018. Epub 2014 Dec 31.
3
Prevention of hepatocellular carcinoma in hepatitis B virus infection.预防乙型肝炎病毒感染中的肝细胞癌
J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x.
4
Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌的预防与监测
Semin Liver Dis. 2005;25 Suppl 1:40-7. doi: 10.1055/s-2005-915649.
5
Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.亚太地区肝细胞癌的预防:共识声明。
J Gastroenterol Hepatol. 2010 Apr;25(4):657-63. doi: 10.1111/j.1440-1746.2009.06167.x.
6
[Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].[慢性病毒性肝炎背景下肝细胞癌的预防策略]
Z Gastroenterol. 2008 Jan;46(1):69-80. doi: 10.1055/s-2007-963684.
7
Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.恩替卡韦对乙型肝炎病毒和肝细胞癌的抑制作用。
J Gastroenterol Hepatol. 2011 Sep;26(9):1380-8. doi: 10.1111/j.1440-1746.2011.06776.x.
8
[Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma].[作为肝细胞癌预防措施的慢性病毒性肝炎的预防与治疗]
Orv Hetil. 2009 Jan 4;150(1):19-26. doi: 10.1556/OH.2009.28529.
9
Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.用于预防乙型肝炎相关肝癌的抗病毒治疗比癌症筛查更具成本效益。
J Hepatol. 2009 May;50(5):990-8. doi: 10.1016/j.jhep.2008.12.022. Epub 2009 Feb 15.
10
Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy.通过抗乙型肝炎病毒治疗预防肝细胞癌及其复发
Minerva Gastroenterol Dietol. 2014 Sep;60(3):191-200. Epub 2014 Jul 8.

引用本文的文献

1
Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights.解读微小RNA在肝细胞癌中的多方面作用:整合文献综述与生物信息学分析以获取治疗见解
Heliyon. 2024 Oct 18;10(20):e39489. doi: 10.1016/j.heliyon.2024.e39489. eCollection 2024 Oct 30.
2
Cancer biotherapy: review and prospect.癌症生物疗法:综述与展望。
Clin Exp Med. 2024 May 27;24(1):114. doi: 10.1007/s10238-024-01376-2.
3
Dynamic evaluation of liver fibrosis to assess hepatocellular carcinoma risk in patients with chronic hepatitis B receiving nucleoside analogs treatment.
动态评估肝纤维化以评估接受核苷类似物治疗的慢性乙型肝炎患者的肝细胞癌风险。
Rev Inst Med Trop Sao Paulo. 2024 May 13;66:e27. doi: 10.1590/S1678-9946202466027. eCollection 2024.
4
Disparities in Healthcare and HBV Vaccination by Smoking Status: Findings from the National Health and Nutrition Examination Survey (NHANES) 2017-2018.吸烟状况与医疗保健及乙肝疫苗接种的差异:2017 - 2018年美国国家健康与营养检查调查(NHANES)的结果
Healthcare (Basel). 2023 Dec 23;12(1):41. doi: 10.3390/healthcare12010041.
5
Development of therapeutic vaccines for the treatment of diseases.用于疾病治疗的治疗性疫苗的研发。
Mol Biomed. 2022 Dec 8;3(1):40. doi: 10.1186/s43556-022-00098-9.
6
Exposure to patients' sample and prevalence of Hepatitis B and C virus infection among health-care workers in a Nigerian Tertiary Hospital.尼日利亚一所教学医院中,医护人员接触患者样本与乙型和丙型肝炎病毒感染流行率的关系。
Ann Afr Med. 2022 Oct-Dec;21(4):322-326. doi: 10.4103/aam.aam_44_21.
7
Nanotheranostic Strategies for Cancer Immunotherapy.用于癌症免疫治疗的纳米诊疗策略。
Small Methods. 2022 Dec;6(12):e2200718. doi: 10.1002/smtd.202200718. Epub 2022 Nov 16.
8
Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria.尼日利亚乔斯地区接受长期抗病毒治疗的慢性乙型肝炎患者中乙型肝炎病毒E基因型及免疫逃逸突变的分子检测
Afr J Lab Med. 2022 Oct 18;11(1):1677. doi: 10.4102/ajlm.v11i1.1677. eCollection 2022.
9
The Cancer Epitope Database and Analysis Resource (CEDAR).癌症抗原数据库与分析资源(CEDAR)。
Nucleic Acids Res. 2023 Jan 6;51(D1):D845-D852. doi: 10.1093/nar/gkac902.
10
A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis.乙型肝炎病毒核心蛋白在肝癌发生中的多效作用。
Int J Mol Sci. 2021 Dec 20;22(24):13651. doi: 10.3390/ijms222413651.